TRENDING :  Market Movers  |  Top 50   SPY (0.23%)    TSLA (-2.49%)    CANF (1.36%)    BYND (-2.96%)    BTCUSD (%)    ONCS (-3.12%)    AMZN (0.43%)    TVIX (-4.25%)    VXX (-2.07%)    ROKU (6.45%)    ACAD (2.45%)    OIH (-1.43%)    MCHP (-1.44%)    MAXR (-13.79%)    IRBT (0.03%)    IP (-0.24%)    INTC (0.09%)    GDX (0.64%)    FTNT (0.33%)    ECOR (-4.53%)    DNR (3.23%)    DIS (0.05%)    DFRG (2.06%)    CMG (-0.69%)    BIOC (9.74%)

 BIOS - BioScrip

$2.05 [0.03][0.99%]

Next Earnings



Trade Idea »


No recommendations found.

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



Friday's ETF Movers: IHF, CQQQ

In trading on Friday the iShares U S Healthcare Providers ETF IHF is outperforming other ETFs up about 1 1 on the day Components of that ETF showing particular strength include shares of Triple S Management GTS up about 3 8 and shares of Bioscrip BIOS up about 3 5 on

BioScrip's Option Care Merger on Track, Q1 Loss Narrows

BioScrip Inc BIOS released certain updates on its ongoing merger with Option Care along with its first quarter earnings release recently The company has entered into a merger agreement with this home and alternate site infusion services provider in March 2019 According to BioScrip

BioScrip (BIOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Wall Street expects fla t earnings compared to the year ago quarter on higher revenues when BioScrip BIOS reports results for the quarter ended March 2019 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that could impact

BioScrip (BIOS) Reports Q1 Loss, Tops Revenue Estimates

BioScrip BIOS came out with a quarterly loss of 0 10 per share versus the Zacks Consensus Estimate of a loss of 0 12 This compares to loss of 0 12 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise of 16 67